Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: Selenium nanoparticles (SeNPs) have potent antitumor activity against prostate cancer cells through the upregulation of miR-16

Fig. 3

SeNP treatment lead to cell apoptosis enhancement in LNCaP and LNCaP-A cells. a, b Cell apoptosis analysis in a LNCaP and b LNCaP-A after SeNP treatment. c, d Cell casepase-3 activities analysis in c LNCaP and d LNCaP-A after SeNP treatment. e, f Expression of Bax in e LNCaP and f LNCaP-A after SeNP treatment. g, h Expression of BCL-2 in a LNCaP and b LNCaP-A after SeNP treatment. SeNP dose: 50 μg

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us